| | |
| South Africa's De Klerk in hospital for heart procedure Monday, Jul 01, 2013 11:45 PM PDT  JOHANNESBURG (Reuters) - South Africa's last white president, FW de Klerk, will undergo a procedure on Tuesday to install a pacemaker, his assistant said. De Klerk, 77, received the Nobel Peace Prize jointly with his successor, Nelson Mandela, in 1993 for overseeing South Africa's transition from white-minority apartheid rule. "He expects to be discharged from hospital within 24 hours. He's going to get a pacemaker and then coming out," de Klerk's personal assistant, Brenda Steyn, told Reuters. ... Full Story | Top |
| Obamacare 1.0: States brace for Web barrage when reform goes live Monday, Jul 01, 2013 11:27 PM PDT  By Sharon Begley NEW YORK (Reuters) - About 550,000 people in Oregon do not have health insurance, and Aaron Karjala is confident the state's new online insurance exchange will be able to accommodate them when enrollment under President Barack Obama's healthcare reform begins on October 1. What Karjala, the chief information officer at "Cover Oregon," does worry about, however, is what will happen if the entire population of Oregon - 3.9 million - logs on that day "just to check it out," he said. ... Full Story | Top |
| Roche buys U.S. blood-testing firm for initial $220 million Monday, Jul 01, 2013 10:42 PM PDT ZURICH (Reuters) - - Swiss drugmaker Roche Holding AG is buying Constitution Medical Investors (CMI), the U.S. developer of a testing system for blood diseases like anemia and leukemia, for an upfront $220 million, plus further contingent payments. Roche, the world's largest maker of cancer drugs, said on Tuesday the contingent payments depended on the achievement of certain milestones, without giving details. It said CMI would strengthen Roche's position in the laboratory hematology testing business, with an estimated global market size of more than $2 billion. ... Full Story | Top |
| South Africa's Mandela still 'critical but stable' Monday, Jul 01, 2013 10:32 PM PDT  JOHANNESBURG (Reuters) - Ailing anti-apartheid leader and former South African President Nelson Mandela remained in hospital on Monday in a "critical but stable" condition, the government said. Mandela has been in a Pretoria hospital for more than three weeks receiving treatment for a recurring lung infection, his fourth hospitalization in six months. The faltering health of the 94-year-old, a figure admired globally as a symbol of struggle against injustice and racism, has reinforced a realization that the father of the post-apartheid South Africa will not be around forever. ... Full Story | Top |
| Yoga in school not same as teaching religion, California judge rules Monday, Jul 01, 2013 06:16 PM PDT By Marty Graham SAN DIEGO (Reuters) - A California judge refused on Monday to block the teaching of yoga as part of a public school's physical fitness program, rejecting parents' claims that the classes were an unconstitutional promotion of Eastern religions. Judge John Meyer acknowledged that yoga "at its roots is religious" but added that the modern practice of yoga, despite its origins in Hindu philosophy, is deeply engrained in secular U.S. society and "is a distinctly American cultural phenomenon. ... Full Story | Top |
| Opponents of Texas abortion restrictions rally at Capitol Monday, Jul 01, 2013 04:46 PM PDT  By Corrie MacLaggan AUSTIN, Texas (Reuters) - Thousands of opponents of a Texas proposal to tighten abortion restrictions rallied outside the statehouse on Monday, giving a hero's welcome to Democratic state Senator Wendy Davis, whose 11-hour speech stalled the measure last week. As the Republican-dominated state legislature convened for a second special session on Monday, supporters said they expected the bill would pass this time. With few exceptions, it would ban abortions after 20 weeks of pregnancy. ... Full Story | Top |
| Pfizer, Novartis may join Amgen in bidding for Onyx: sources Monday, Jul 01, 2013 03:37 PM PDT By Soyoung Kim and Jessica Toonkel NEW YORK (Reuters) - Onyx Pharmaceuticals Inc , whose cancer drugs promise a strong revenue stream, is attracting preliminary buyout interest from several large pharmaceutical companies such as Pfizer Inc and Novartis AG , two people familiar with the matter said on Monday. Onyx, a biotechnology company with a market value of around $9.5 billion, put itself up for sale on Sunday, citing "expressions of interest" from unnamed companies. It also said it had rejected a recent $8.7 billion offer from larger biotech Amgen Inc as too low. ... Full Story | Top |
| Lawyers ask U.S. judge to halt Guantanamo force-feedings Monday, Jul 01, 2013 02:01 PM PDT  By Jane Sutton MIAMI (Reuters) - Lawyers for four Guantanamo prisoners are asking a U.S. federal judge to block the force-feeding of hunger strikers at the detention camp, arguing that it violates human rights and serves no military purpose. The lawsuit was filed on Sunday night in Washington and U.S. District Judge Rosemary Collyer gave the government until noon (1600 GMT) on Wednesday to reply. The U.S. military holds 166 foreign captives at the detention camp on the Guantanamo Bay U.S. ... Full Story | Top |
| Fewer children being injured on ATVs: study Monday, Jul 01, 2013 01:25 PM PDT By Genevra Pittman NEW YORK (Reuters Health) - The number of U.S. children injured while riding all-terrain vehicles (ATVs) has fallen since 2004, according to a new study of emergency room records. Researchers said it's not clear if that trend is due to fewer kids riding ATVs in the first place - possibly for financial reasons - or to better safety practices, such as helmet use. Ruth Shults, of the Centers for Disease Control and Prevention's National Center for Injury Prevention and Control, and her colleagues analyzed information from a U.S. ... Full Story | Top |
| Unnecessary repeat cholesterol tests common: study Monday, Jul 01, 2013 01:04 PM PDT By Genevra Pittman NEW YORK (Reuters Health) - One-third of people with heart disease have their cholesterol levels checked more often than guidelines recommend, a new study of Veterans Affairs (VA) patients suggests. Researchers said such extra testing may be a waste of time and money if it doesn't lead to improvements in patients' health. The findings are "very unsurprising," according to Dr. Michael Johansen of The Ohio State University in Columbus, who has studied cholesterol management. ... Full Story | Top |
| Red meat tied to worse colon cancer outcomes: study Monday, Jul 01, 2013 01:03 PM PDT By Andrew M. Seaman NEW YORK (Reuters Health) - People who report eating the most red and processed meat before being diagnosed with colon cancer are more likely to die during the next eight years, according to a new study. "It's another important reason to follow the guidelines to limit the intake of red and processed meat," said Marjorie McCullough, the study's lead author from the American Cancer Society in Atlanta. ... Full Story | Top |
| Hitler's food taster feared death with every morsel Monday, Jul 01, 2013 12:01 PM PDT By Michelle Martin BERLIN (Reuters) - Margot Woelk spent the last few years of World War Two eating lavish meals and fearing that every mouthful could mean death. The former food taster for Adolf Hitler was served a plate of food and forced to eat it between 11 and 12 every morning for most of the last 2-1/2 years of the Nazi German leader's life. If she did not fall ill, the food was packed into boxes and taken to Hitler at the Wolf's Lair, a military headquarters located deep in woodland, in what is today northeastern Poland. ... Full Story | Top |
| CORRECTED-Obamacare 1.0: States brace for Web barrage when reform goes live Monday, Jul 01, 2013 11:58 AM PDT  By Sharon Begley NEW YORK (Reuters) - About 550,000 people in Oregon do not have health insurance, and Aaron Karjala is confident the state's new online insurance exchange will be able to accommodate them when enrollment under President Barack Obama's healthcare reform begins on October 1. What Karjala, the chief information officer at "Cover Oregon," does worry about, however, is what will happen if the entire population of Oregon - 3.9 million - logs on that day "just to check it out," he said. ... Full Story | Top |
| FDA rejects Merck insomnia drug, seeks lower-dose Monday, Jul 01, 2013 10:17 AM PDT (Reuters) - U.S. health regulators have rejected Merck & Co's new insomnia drug application but opened the door to approving a lower-dose version of the medication, the company said on Monday. Merck said it received a complete response letter from the U.S. Food and Drug Administration saying that the agency could consider a 10 milligram starting dose of suvorexant for most patients, but that the company would have to have that dosage ready before it could be approved. ... Full Story | Top |
| Insmed's lung infection drug fares no better than rival, shares fall Monday, Jul 01, 2013 07:38 AM PDT (Reuters) - Insmed Inc's experimental lung infection drug fared no better than a competing drug developed by Novartis AG in a lung function test, sending shares in the company down 27 percent in pre-market trading. Insmed's drug, Arikace, was being tested as a treatment for a bacterial lung infection that often affects cystic fibrosis patients. Insmed said in a statement that the trial met its main goal of showing that Arikace was not inferior to the competing drug. ... Full Story | Top |
|
No comments:
Post a Comment